BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 15330192)

  • 1. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
    Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
    Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
    Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
    Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
    Urso C
    Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
    Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
    Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF and NRAS mutations in spitzoid melanocytic lesions.
    Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
    Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T1796A mutation of the BRAF gene is absent in Spitz nevi.
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Hügel H; Flaig MJ; Yazdi AS; Sander CA; Kutzner H
    J Cutan Pathol; 2004 Mar; 31(3):266-70. PubMed ID: 14984580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
    Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M
    J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of BRAF mutations in Spitz nevi.
    Gill M; Renwick N; Silvers DN; Celebi JT
    J Invest Dermatol; 2004 May; 122(5):1325-6. PubMed ID: 15140238
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
    Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
    J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
    van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
    J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features.
    van Engen-van Grunsven AC; van Dijk MC; Ruiter DJ; Klaasen A; Mooi WJ; Blokx WA
    Am J Surg Pathol; 2010 Oct; 34(10):1436-41. PubMed ID: 20871217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spitz melanoma is a distinct subset of spitzoid melanoma.
    Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
    Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of DNA ploidy measurements in Spitz nevi.
    Skowronek J; Warchoł JB; Karaś Z; Krenz RM
    Pol J Pathol; 2000; 51(1):45-50. PubMed ID: 10833903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
    Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
    Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silhouette symmetry: an unsupportable histologic criterion for distinguishing Spitz nevi and compound nevi from malignant melanoma.
    Okun MR
    Arch Pathol Lab Med; 1997 Jan; 121(1):48-53. PubMed ID: 9111092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.